Sun Pharma Q3 Profit Up 16% to ₹3,369 Cr, Beats Estimates
Sun Pharmaceutical Industries reported a 16% rise in Q3FY26 net profit to ₹3,369 crore, surpassing analyst expectations. Revenue grew 15.1% to ₹15,469 crore, driven by strong performance in India and global innovative medicines.